Company Kimba Pharmaceutical S.r.l. with Fiscal Code 41441322
recorded a turnover of 2024 of
60.290,
with a net profit of
33.748
and having an average number of employees of
1.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 0.0%, from 60.609 euro in the year 2023, to 60.290 euro in 2024.
The Net Profit decreased by -4.146 euro, from 38.107 euro in 2023, to 33.748 in the last year.
Check the financial reports for the company - Kimba Pharmaceutical S.r.l.
Financial Rating - KIMBA PHARMACEUTICAL S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Kimba Pharmaceutical S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Kimba Pharmaceutical S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Kimba Pharmaceutical S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
149.475 euro in 2024 which includes Inventories of
3.355 euro, Receivables of
124.631 euro and cash availability of
21.489 euro.
The company's Equity was valued at
141.212 euro, while total Liabilities amounted to
11.802 euro.
Equity increased by 33.748 euro, from 108.068 euro in 2023, to 141.212 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Kimba Pharmaceutical S.r.l.